Tiger Eye Capital’s Agilent Technologies A Stock Holding History

Tiger Eye Capital’s Portfolio A Stock Details A Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-253,612	Closed	-$17M	–	43
2018 Q1	$17M	Buy	+253,612	New	+$17.8M	3.73%	14

Other funds holding A

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Tiger Eye Capital's A Position: Q2 2018 in Review

Tiger Eye Capital sold out of Agilent Technologies (A) in Q2 2018, closing a stake of 253,612 shares — an estimated $17M sold.

Tiger Eye Capital first reported a position in A in Q1 2018 and held it in 1 quarter. The position peaked at $17M in Q1 2018. 668 funds tracked by Wall St. Rank hold A as of Q2 2018.

Tiger Eye Capital reported no remaining Agilent Technologies position as of Q2 2018 after selling out during the quarter.
Tiger Eye Capital sold 253,612 Agilent Technologies shares in Q2 2018, an estimated $17M.
Tiger Eye Capital first reported a position in Agilent Technologies in Q1 2018 and held it in 1 quarter.
Tiger Eye Capital's Agilent Technologies position peaked at $17M in Q1 2018.
668 funds tracked by Wall St. Rank held Agilent Technologies as of Q2 2018.

Based on Tiger Eye Capital's 13F filing for Q2 2018, filed 13 Aug 2018.